Lance M Westerhoff
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2014First federal award
$6.2MFederal grants as PI14 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
14 awards · $6.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 20, 2026 | NIH | SBIR Phase II Addressing Structural Disorder and Conformational Heterogeneity in Modern Therapeutic Modalities: A Unified X-ray/Cryo-EM QM/MM Ensemble Refinement Toolkit with Enhanced Density-Driven MD | $684K | QUANTUMBIO INC |
| Sep 17, 2025 | NIH | SBIR Phase II Addressing Structural Disorder and Conformational Heterogeneity in Modern Therapeutic Modalities: A Unified X-ray/Cryo-EM QM/MM Ensemble Refinement Toolkit with Enhanced Density-Driven MD | $254K | QUANTUMBIO INC |
| Nov 14, 2024 | NIH | SBIR Phase II Research and cloud deployment of enhanced sampling methods in MovableType | $654K | QUANTUMBIO INC |
| Dec 5, 2023 | NIH | SBIR Phase II Research and cloud deployment of enhanced sampling methods in MovableType | $654K | QUANTUMBIO INC |
| May 5, 2023 | NIH | SBIR Phase II Research and cloud deployment of enhanced sampling methods in MovableType | $208K | QUANTUMBIO INC |
| Feb 2, 2021 | NIH | SBIR Phase II Research and deployment of binding-domain flexible MovableType (MTFlex) for free energy-based affinity prediction and crystallographic structure determination | $513K | QUANTUMBIO INC |
| Jan 31, 2020 | NIH | SBIR Phase II Research and deployment of binding-domain flexible MovableType (MTFlex) for free energy-based affinity prediction and crystallographic structure determination | $513K | QUANTUMBIO INC |
| Aug 1, 2019 | NIH | SBIR Phase II Research and deployment of binding-domain flexible MovableType (MTFlex) for free energy-based affinity prediction and crystallographic structure determination | $153K | QUANTUMBIO INC |
| Dec 3, 2018 | NIH | SBIR Phase II Development of the Movable Type free energy method for ligand placement in X-ray crystallography | $543K | QUANTUMBIO INC |
| Nov 28, 2017 | NIH | SBIR Phase II Development of the Movable Type free energy method for ligand placement in X-ray crystallography | $548K | QUANTUMBIO INC |
| Mar 30, 2017 | NIH | SBIR Phase II Development of the Movable Type free energy method for ligand placement in X-ray crystallography | $166K | QUANTUMBIO INC |
| Mar 16, 2016 | NIH | SBIR Phase II Development and Deployment of the Movable Type Method for Drug Discovery and Desi | $561K | QUANTUMBIO INC |
| Mar 10, 2015 | NIH | SBIR Phase II Development and Deployment of the Movable Type Method for Drug Discovery and Desi | $571K | QUANTUMBIO INC |
| Nov 20, 2014 | NIH | SBIR Phase I A new approach to solvent determination in QM/MM-based X-ray crystallographic refinement | $141K | QUANTUMBIO INC |
Peer ranks
Federal funding#175
Awards as PI#57
Patents#273
Companies
- QUANTUMBIO INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.